FDA/HESI-ITC Workshop on Safety Assessment of Engineered T cell Therapies
September 24, 2019 ‐ September 25, 2019 in Silver Spring, Maryland (USA)
The FDA/HESI-ITC Workshop on Safety Assessment of Engineered T cell Therapies will be held from September 24-25, 2019 in Silver Spring, Maryland.
Roman Galetto, Ph.D., Preclinical Manager, Cellectis, will participate in this event on September 24, by giving a presentation on “TALEN-mediated multiplex gene edited CAR T-cells: preclinical evaluation of allogeneic cell therapy products” from 9:30-10:15 AM EDT.